Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Soleno Therapeutics, Inc. (SLNO : NSDQ)

• Company Description    Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief. Soleno Therapeutics Inc., formerly known as Capnia Inc., is based in Vancouver, Canada. Number of Employees: 92

• Price / Volume Information    Yesterday's Closing Price: $80.32 Daily Weekly Monthly 20 Day Moving Average: 1,279,396 shares Shares Outstanding: 50.39 (millions) Market Capitalization: $4,047.64 (millions) Beta: -2.63 52 Week High: $90.32 52 Week Low: $41.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.15% -3.60% 12 Week 14.78% -3.46% Year To Date 78.69% 67.34%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 100 MARINE PARKWAY SUITE 400 - REDWOOD CITY,CA 94065 USA ph: 650-213-8444 fax: 650-213-8383 info@soleno.life http://www.soleno.life

• General Corporate Information    Officers Anish Bhatnagar - President; Chief Executive Officer and Director James Mackaness - Chief Financial Officer Matthew Pauls - Lead Independent Director Andrew Sinclair - Director William G. Harris - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 834203309 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/06/25 Share - Related Items Shares Outstanding: 50.39 Most Recent Split Date: 8.00 (0.07:1) Beta: -2.63 Market Capitalization: $4,047.64 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.75 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-3.05 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 17.26 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -61.02% vs. Previous Quarter: 25.20% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - -77.52 12/31/24 - -75.31 ROA 06/30/25 - - 03/31/25 - -63.44 12/31/24 - -63.91 Current Ratio 06/30/25 - - 03/31/25 - 19.64 12/31/24 - 15.68 Quick Ratio 06/30/25 - - 03/31/25 - 19.64 12/31/24 - 15.68 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 4.65 12/31/24 - 5.68 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.21 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 17.67 12/31/24 - 0.00

Powered by Zacks Investment Research ©